Close Menu

NEW YORK (GenomeWeb) – University of Liverpool (UL) researchers said today that they have received £1.6 million ($2.2 million) to develop a commercial blood test to improve the diagnosis and management of patients with suspected meningitis, a brain infection that causes disability and sometimes death.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.